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Abstract
Background Impairment of mitochondrial function plays an
important role in obesity and the development of insulin
resistance. The aim of this project was to investigate the
mitochondrial DNA copy number in human omental
adipose tissue with respect to obesity.
Methods The mitochondrial DNA (mtDNA) content per
single adipocyte derived from abdominal omental adipose
tissue was determined by quantitative RT-PCR in a group of
75 patients, consisting of obese and morbidly obese
subjects, as well as non-obese controls. Additionally, basal
metabolic rate and fat oxidation rate were recorded and
expressed as total values or per kilogram fat mass.
Results MtDNA content is associated with obesity. Higher
body mass index (BMI) resulted in a significantly elevated
mtDNA count (ratio=1.56; p=0.0331) comparing non-
obese (BMI<30) to obese volunteers (BMI≥30). The
mtDNA count per cell was not correlated with age or
gender. Diabetic patients showed a trend toward reduced
mtDNA content. A seasonal change in mtDNA copy
number could not be identified. In addition, a substudy
investigating the basal metabolic rate and the fasting fat
oxidation did not reveal any associations to the mtDNA
count.
Conclusions The mtDNA content per cell of omental
adipose tissue did not correlate with various clinical
parameters but tended to be reduced in patients with
diabetes, which may partly explain the impairment of
mitochondrial function observed in insulin resistance.
Furthermore, the mtDNA content was significantly in-
creased in patients suffering from obesity (BMI above 30).
This might reflect a compensatory response to the devel-
opment of obesity, which is associated with impairment of
mitochondrial function.
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Introduction
Human adipose tissue is now well recognized as a
multifunctional organ. It is the location of lipid storage
and, with its brown tissue islets, plays an important role
in thermogenesis [1]. Adipose tissue, especially intra-
abdominal and omental fat compartments, also has
various endocrine functions [2], as it is the source of
different peptide hormones and adipokines [3] such as
adiponectin, IL-6, leptin, plasminogen activator inhibitor-
1, resistin, or visfatin. These and other factors, in
particular mitochondria, have been shown to be associated
with the development of obesity, insulin resistance, and
type 2 diabetes [4–8].
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Mitochondria represent a major portion of the energy
generating pathways, and the extent of energy expenditure
or lipid storage is directly associated with the functional
state of mitochondria. In the mitochondrial inner mem-
brane, a highly regulated electron transfer chain uses a
proton gradient to synthesize ATP formed from ADP and
phosphate, named oxidative phosphorylation [9]. The
uncoupling of this process by, e.g., uncoupling proteins
leads to thermogenesis in brown adipocytes [10], as
opposed to white adipocytes, which contain mitochondria
of a kind different from those in brown adipose tissue [11].
It is well known that different types of cells or tissue
contain different subsets of mitochondria or, rather, that
mitochondria display heterogeneous morphology within
individual cells [12].
The number of mitochondria per cell and the rate of
mitochondrial turnover [13] also vary among different
tissues [14]. While liver cells, muscle cells, or brown
adipocytes contain a relatively high number of mitochon-
dria per cell, the mitochondrial count in white adipocytes is
much lower. The biogenesis of mitochondria and, thus,
their numbers are controlled by different extracellular and
intracellular stimuli [15], including environmental influen-
ces, such as a cold response via the peroxisome proliferator-
activated receptor γ coactivator 1α (PGC-1a), which leads
to an increase in the mitochondrial mass, mitochondrial
function (mt capacity), and mitochondrial DNA content
[16]. Recently, temperature conditions such as the climate
with its seasons have been described as a cold-response
factor [17]. The mitochondrial content of cells is also
controlled by fission and fusion processes [18, 19], as
mitochondria are able to divide or fuse. By fusion,
mitochondria share mitochondrial proteins, exchange mito-
chondrial DNA, and can restore function. Fusion is
followed by a fission process, which leads to newly
“rebuilt” or “refurbished” mitochondria. This fusion–fission
process may be dysregulated in obesity. A high fusion-to-
fission ratio leads to fewer mitochondria forming long
interconnections [19]. On the other hand, a low fusion-to-
fission ratio results in fragmentation of mitochondria, with
the consequence of an increase in the mitochondrial content
per cell. An association of disturbed fusion and fission
processes with the development of obesity was recently
detected by a reduced expression of mitofusions (e.g., mfn-
2) [20], leading to a more fragmented population of
mitochondria and, therefore, to a higher mitochondrial
content per cell [21].
Apart from obesity, type 2 diabetes and insulin resistance
have also been shown to be linked to mitochondrial
function and mitochondrial density. For example, adipo-
cytes from diabetic ob/ob mice show a decreased number of
mitochondria per cell, an effect that can be reversed by
treatment with PPAR-γ agonists such as rosiglitazone [22].
Thus, the development of insulin resistance appears to be
associated with a reversible decrease of mitochondrial
density.
Little is known about mitochondrial content and function
in human omental fat in various states of obesity and the
metabolic syndrome [8]. The aim of the present study was
to evaluate the mitochondrial DNA (mtDNA) content per
cell in human omental adipose tissue from a group of 75
participants, including 52 obese patients (BMI≥30) and 23
non-obese controls (BMI<30), and to correlate the mito-
chondrial count per adipocyte with the clinical parameters,
“basal metabolic rate” and “fat oxidation rate.” Within our
patient group, 18 of the 75 volunteers suffered from
diabetes.
Patients and Methods
Patients The study was approved by the local ethics
committee. The patients participated on a voluntary basis
after having given written informed consent. The patient
group consisted of 52 morbidly obese patients undergoing
bariatric surgery: laparoscopic proximal Roux-en-Y gastric
bypass (n=29), laparoscopic biliopancreatic diversion “du-
odenal switch” (n=15, all but two after failed laparoscopic
adjustable gastric banding) [23, 24], and laparoscopic
sleeve resection (n=8). Their average BMI was 42 kg/m2;
16 patients were diabetics (for more details, see Table 2).
The non-obese control group consisted of 23 patients who
planned to undergo elective surgery: colorectal (n=12),
pancreas (n=5), esophagus (n=3), stomach, cholecystecto-
my, and oophorectomy (n=1 each). Their average BMI was
25 kg/m2; two of them were diabetics (Table 2). The group
of non-obese patients did not include any post-bariatric
surgery patient who reduced body weight (re-operation).
Diabetic patients were analyzed under ongoing diabetic
treatments (metformin and insulin). Patients on glitazone-
based therapy were excluded, because glitazones stimulate
mitochondrial biogenesis.
All data were collected prospectively. Obese patients and
non-obese controls were carefully characterized prior to
surgery for metabolic syndrome and other co-morbidities.
In obese patients, body composition was determined by
dual energy X-ray absorptiometry; energy consumption,
including basal metabolic and fat oxidation rates, was
measured by indirect calorimetry. The omental fat tissue
samples were collected during the operation and immedi-
ately shock frozen in liquid nitrogen and stored at −78°C.
DNA Isolation Taqman-based quantification of the mtDNA
count per cell was performed with DNA prepared from
frozen adipose tissue according to the standard manual
(NucleoSpin DNA, Machery Nagel, Germany).
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Determination of mtDNA Copy Number The quantification
of the mitochondrial DNA count per cell is an approxima-
tion to the measurement of the mitochondrial mass to
bypass limitations from the small sizes of tissue biopsies.
Quantitative RT-PCR was applied to determine the relative
amounts of mtDNA and nuclear DNA [25], from which
their relative ratio was calculated. One single-copy gene
from the genome (lipoprotein lipase (LPL)) and one from
the mitochondrial genome (NADH dehydrogenase subunit
1 (ND1)) were used for amplification. In addition,
amplified DNA fragments from plasmids carrying either
ND1 or LPL fragments were used as standards to determine
accurate quantities of mtDNA content in the samples of
interest. Per tissue biopsy the determination of the mtDNA
count was performed in duplicate to judge the precision of
measured data (see Statistics).
Primers and Probes LPL-probe: ACA-TTC-ACC-AGA-
GGG-TC with 3′ Tamra and 5′ FAM. ND1-probe: CCA-
TCA-CCC-TCT-ACA-TCA-CCG-CCC with 3′ Tamra and
5′ FAM. Oligos used for amplification: LPL-fwd CGA-
GTC-GTC-TTT-CTC-CTG-ATG-AT; LPL-rev TTC-T
GG-ATT-CCA-ATG-CTT-CGA and ND1-fwd CCC-TAA-
AAC-CCG-CCA-CAT-CT; ND1-rev GAG-CGA-TGG-
TGA-GAG-CTA-AGG-T.
Statistics First, univariate analysis was performed to ana-
lyze effect of age, gender, season, diabetes, or BMI on the
mtDNA count. To compare seasonal-dependent mtDNA
copy number at the time of tissue sampling, two groups
“winter” (1 November to 31 March) and “summer” (1 April
to 31 October) were formed to describe the seasons. The
calculation of diabetes-associated influence on the mtDNA
content was done by comparing diabetic patients and
non-diabetics.
The univariate analysis applied to describe effects of age,
gender, season, diabetes, or BMI on the mtDNA count was
performed as follows: SPSS software was applied to
determine the two-tailed Fischer’s exact test in case of
contingency tests. Graphpad Prism software was used to
calculate mean ± SEM and unpaired t test (95% confi-
dence). In addition, the correlation analysis between
mtDNA copy number and metabolic rates or fat oxidation
rates was performed with Graphpad Prism software using
Spearman-ratio-based correlation models. p values <0.05
were considered as significant.
Multivariate Analysis Based on the results from the
univariate statistics, an in-depth analysis was performed to
detect the influence of BMI or diabetes on the number of
mitochondria by using a linear, mixed-effect model. Mixed-
effect models were used to evaluate repeated measure data
where observations were correlated within the same subject
[26]. “Precision of measured data,” “age,” “gender,”
“BMI,” and “diabetes” were fixed factors; “subject” was
treated as a random factor. Consequently, the results are
adjusted for age, gender, precision of measured data,
diabetes, and BMI. As the mitochondria counts were
approximately log-normal distributed, these variables were
log-transformed. Hence, back-transformed group differ-
ences from the mixed-effect model are expressed as
geometric mean ratios with corresponding 95% confidence
intervals.
A p value <0.05 was considered significant. Statistical
analysis was performed using R (a language and environ-
ment for statistical computing).
Results
Univariate Analysis
According to the literature, age [27], gender [28], or season
[17] can have an impact on the mitochondrial count or
function. In our analysis these parameters did not correlate
with the mtDNA count. Neither age (ratio=−0.1513; p=
0.1952; n=75), nor gender (women 611.8±53.12, n=56
and men 438.3±63.74, n=19; p=0.0828; n=75), nor
season (summer 584.4±61.18, n=41 and winter 548.0±
62.23, n=34; p=0.6798; Table 1) revealed any association
to the mtDNA copy number.
The next point was to clarify a possible impact of the
BMI on the mtDNA copy number. In a univariate analysis,
all 75 patients were dichotomized according to their BMI
(BMI<30 and BMI≥30 kg/m2). The obese group revealed a
significantly increased mtDNA content compared to the
non-obese (634.0±55.54 vs. 418.4±56.53; p=0.0213;
Table 2). Within the two groups of obese and non-obese
patients, no differences in the distribution for gender or
season could be detected (Table 2). In contrast, the non-
obese group was significantly older (59.09±3.276 vs.
48.44±1.817; p=0.0032; Table 2). In the obese group
significantly more patients suffered from diabetes (30.8%
vs. 8.7%; p=0.0444; Table 2).
As the frequency of diabetes paralleled obesity, we
divided the patient pool according to the status of diabetes.
In addition, diabetes has previously been reported as a risk
factor for mitochondrial mass and function [29]. When the
patients were grouped into diabetics and non-diabetics, a
trend toward a reduced mtDNA content in diabetics was
observed; this, however, was not significant (448.7±58.85
vs. 605.5±53.43; p=0.1246; Table 3). In this analysis
according to diabetes, the distributions for age, gender, and
season were equal (Table 3). In analogy to the association
of diabetes with increased BMI as described above, the
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BMI showed a significantly unequal distribution (non-
diabetics 35.36±1.283, n=57 and diabetics 41.07±1.951,
n=18; p=0.0273; Table 3) for the two groups.
Multivariate Analysis
Based on the observations from the univariate analyses, in-
depth statistics were performed using a linear mixed-effect
model. This calculation method incorporates influences
from age, gender, precision of measurements, as well as
BMI and diabetes. However, neither age (ratio=0.98; p=
0.7598), gender (ratio=0.81; p=0.3052), nor precision of
measured data (ratio=1.06; p=0.128; Table 4) had relevant
impact on the mtDNA content. According to this linear
mixed model, the mtDNA copy number was not signifi-
cantly reduced in diabetics but showed a trend of a 29%
reduced mtDNA content (ratio=0.71; p=0.1003; n=75;
Table 4).
However, grouping the participants into obese patients
and non-obese controls revealed a significantly increased
mtDNA count in the obese group, where the mtDNA count
was elevated by 56% (ratio=1.56; p=0.0331; n=75;
Table 4).
The determination of the mtDNA copy number by
polymerase chain reaction on DNA from tissue biopsies is
an invasive method. Measuring energy expenditure could be
an alternative clinical tool for the measurement of mitochon-
drial function and count. We were able to perform
calorimetry and body composition measurements with 22
(fasting fat oxidation) or 23 obese patients (basal metabolic
rate) but due to logistic reasons, not with non-obese control
patients. Within this group of obese patients the mtDNA
content per adipocyte showed no significant correlation with
the basal metabolic rate (ratio=−0.3538; p=0.0977; n=23)
or the basal metabolic rate per kg fat mass (ratio=0.1038; p=
0.6376; n=23; Table 5). In addition, correlating fasting fat
oxidation rate and mtDNA content (ratio=−0.3123; p=
0.1571; n=22) or fat oxidation rate per kilogram fat mass
and mtDNA count (ratio=−0.2897; p=0.1910; n=22) did
not reflect any associations (Table 5).
Discussion
The aim of this present study was to determine the
mtDNA content of omental adipose tissue with respect to
obesity as well as to investigate possible associations of
the mtDNA count with different parameters such as age,
season, gender, diabetes, basal metabolic rate, and fat
oxidation rate. Adult human adipose tissue is present in
two main compartments—white subcutaneous tissue and
intra-abdominal adipose tissue. Brown adipose tissue, an
important compartment in rodents, has only recently been
described in humans in small amounts in the upper part of
the body [30]. While white adipose tissue mainly serves as
a storage of energy, the abdominal adipose tissue is, in
addition, an important source of various hormones and
mediators linking abdominal obesity with the metabolic
syndrome [31]. Mitochondrial dysfunction leading to
impaired oxidation of fatty acids has been proposed as
the culprit in diabetes [32]. Diabetes, hypercholesterine-
mia, and arterial hypertension—the main features of the
Parameter Obese patient group (BMI≥30) Controls (BMI<30) p
n=52 n=23
BMIa 41.97±0.8544 24.87±0.7249 <0.0001
Agea 48.44±1.817 59.09±3.276 0.0032
Genderb(females/males) 42/10 14/9 0.0871
Seasonb(summer/winter) 29/23 12/11 0.8058
Diabetesc 16 (30.8%) 2 (8.7%) 0.0444
Diet 10 1
Oral drugs 5 0
Insulin 1 0
mtDNA counta 634.0±55.44 418.4±56.53 0.0213
Table 2 Univariate analysis of
the mitochondrial DNA count
according to the BMI
a Unpaired t test (95% confi-
dence), mean ± SEM; Prism
Graphpad software
b Two-tailed Fischer’s test; SPSS
software
c None of the diabetes patients
were on glitazone-based anti-
diabetic treatment
Summer Winter p
n=41 n=34
MtDNA copy numbera 584.4±61.18 548.0±62.23 0.6798
Women/menb 30/11 (73.17%/26.83%) 26/8 (76.47%/23.53%) 0.795
BMIa 37.19±1.547 36.17±1.615 0.6487
Diabetes/non-diabeticsb 9/32 (21.95%/78.05%) 9/25 (26.47%/73.53%) 0.7871
Table 1 Univariate analysis of
the mitochondrial DNA count
and season of tissue sampling
aMean ± SEM, p value (Prism
software)
b Fisher’s exact test (SPSS soft-
ware)
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metabolic syndrome—lead to macrovascular disease, the
most important cause of death in obesity. While mito-
chondria of white subcutaneous adipose tissue and skeletal
muscle have already been studied in humans [33, 34], we
here present the first study on the mtDNA content in
human omental fat tissue.
In general, our data indicate that the mtDNA content of
human fat omental tissue is relatively stable. This is in line
with results from subcutaneous fat tissue, which also
showed relative stable mitochondrial copy numbers under
various conditions [35]. The number of mtDNA copies in
adipose tissue is up to 10-fold smaller than that in muscle
tissue [36]. This smaller number of mtDNA copies is the
consequence of a reduced number of mitochondria in
adipocytes. The reason for this may be the specialized
function of this tissue. While muscle cells have to produce
high amounts of energy for contraction, adipocytes have
different functions. One main task is to store energy in form
of triglycerides [3, 37–39]. Generally, it is very difficult to
determine the exact number of mitochondria or mitochon-
drial mass from tissue samples of the small size used in this
study. However, determination of the mtDNA copy number
is a possibility to express changes in mitochondrial mass or
number. It has been documented that increasing numbers of
mtDNA copy number are associated with an increased
“virtual” number of mitochondria per cell [40]. This virtual
number of mitochondria per cell is regarded as a number of
mitochondrial fragments forming a huge mitochondrial
interconnected network or as a number for independent
mitochondria [40].
First, we analyzed the data by univariate analyses to
detect effects of age, gender, and season on the mtDNA
content per adipocyte. No correlation could be detected
between age and the mtDNA content (ratio=−0.1513; p=
0.1952; n=75). Aging is seen as a major source of free
radicals that are harmful for mitochondria [34, 35].
However, it seems that, in human omental tissue, aging
does not lead to reduced mtDNA content. Separation of all
patients by gender showed a weak trend toward reduced
mtDNA content for male patients (women 611.8±53.12,
n=56 and men 438.3±63.74, n=19; p=0.0828; n=75). The
tendency of reduced mtDNA copy number in the male
group of patients is not significant and remains unclear. It
could be due to a smaller number of male patients (n=19)
than of female patients (n=56). Therefore, further study of
gender-specific mtDNA content in omental adipose tissue is
needed. Finally, the grouping of patients by season of
sample collection did not reflect any differences in mtDNA
copy number (summer 584.4±61.18, n=41 and winter
548.0±62.23, n=34; p=0.6798; Table 1). Cold-induced
thermogenesis is a well-described mechanism, which leads
to increased mitochondrial count and mass, mainly in
brown adipose tissue of rodents and skeletal muscle [16],
primarily controlled by activation of PGC-1a. Thus, in the
present study the mtDNA copy number and the season
could not be correlated to the season of tissue sampling.
Table 3 Univariate analysis of the mtDNA count according to the presence or absence of diabetes
Parameter Diabetics Controls (non-diabetic) p
n=18 n=57
Agea 55.44±2.972 50.53±2.015 0.2183
Genderb(females/males) 43/14 13/5 0.7647
BMIa 41.07±1.951 35.36±1.283 0.0273
Seasonb(summer/winter) 9/9 32/25 0.7871
mtDNA countc 448.7±58.85 605.5±53.43 0.1246
a Unpaired t test (95% confidence), mean ± SEM; Prism Graphpad software
b Two-tailed Fischer’s test; SPSS software
c None of the diabetes patients were on glitazone-based anti-diabetic treatment
Table 4 Multivariate analysis (linear mixed-effect model); n=75
Geometric mean ratio 95% confidence interval pvalue
Age 0.98 0.86 to 0.98 0.7598
Gender 0.81 0.55 to 1.21 0.3052
Precision of measurementsa 1.06 0.98 to 1.15 0.128
BMI (obese=52; non-obese=23) 1.56 1.04 to 2.34 0.0331
Diabetes (diabetes=18; healthy controls=57) 0.71 0.47 to 1.07 0.1003
a Per tissue biopsy the determination of the mtDNA count was performed in duplicate to judge the precision of measured data
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However, the seasons were equally distributed in the groups
of obese patients and non-obese controls (Tables 1 and 2)
and in diabetic and non-diabetic patients (Tables 2 and 3). It
appears that omental adipose tissue is not affected by
seasonal changes of the outside temperature in the range
present in Switzerland. This is less surprising, as only
recently cold-inducible brown adipose tissue in the upper
part of the human body was detected using PET scanners
[41, 42]. This tissue may be responsible for cold-induced
thermogenesis [17].
Obesity is regarded to have an impact on mitochondrial
function. Therefore, we distributed the participants into two
BMI groups, an obese group and a group of non-obese
controls. To identify a possible impact of obesity on
mitochondria, the mtDNA copy numbers were calculated
and compared between the non-obese control group and the
obese patients. The mtDNA count (p=0.0213; Table 2) was
significantly increased in obesity. The higher mtDNA count
in the obese group clearly links the mitochondrial DNA
content in omental adipose tissue to the development of
obesity. This may be a mechanism to compensate for
mitochondrial dysfunction or other mitochondrial defects,
which will be discussed later. Age also showed a significant
difference in distribution (p=0.0032, Table 2). The younger
age in the obese group is primarily caused by the type of
surgical intervention. Bariatric surgery is generally only
applied to patients between 20 and 60 years of age, whereas
in the control group the cause for abdominal surgery was
not restricted to age. The two BMI groups differed neither
by gender distribution (p=0.0871, Table 2) nor by the
season the samples were collected (p=0.8058, Table 2).
Within the two BMI groups, the distribution of diabetes
was not equal (p=0.0444; Table 2). This is not surprising as
diabetes is associated with increased body weight.
It is well accepted that diabetes can have an impact on
mitochondrial mass and function [29]. In order to investi-
gate this point in human omental adipose tissue, we
grouped the patients according to diabetes; the BMI was
significantly higher in the group of diabetics (p=0.0273,
Table 3). This is in line with data distributed according to
the BMI (see above) and links diabetes to obesity. The
distribution of other parameters such as age (p=0.2183),
gender (p=0.7647), or season (p=0.7871; Table 3) did not
show any inequality for the diabetes grouping (Table 3).
Finally, the mtDNA count was reduced in the diabetes
group but failed to be significant (p=0.1246; Table 3). The
limited number of diabetic patients, which will be discussed
later, does not allow further conclusions. Further studies,
including more diabetics, are needed.
Based on the findings above, showing some possible
influences of age, diabetes, and BMI on the mtDNA count,
a linear mixed model was applied to allow a multivariate
analysis of the present data.
This multivariate interpretation revealed that the mtDNA
copy number did not change with increasing age (ratio=
0.98; p=0.7598; Table 4). This is in contrast to the general
view that accumulation of free radical oxygen species
during lifetime leads to impairment of mitochondria [34]
and, as a consequence, to a reduced mitochondrial content
in white subcutaneous tissue [35]. On the other hand,
mtDNA content has been reported to be stable in skeletal
muscle, a tissue with high mitochondrial activity, high
production rate of reactive oxygen species, and, therefore,
high risk for mitochondrial damage [36].
Although there are gender-specific trends in fat tissue
distribution—women in general showing more subcutane-
ous fat—this does not apply in the case of the mtDNA
content in human omental adipose tissue (ratio=1.06; p=
0.128; Table 4).
Patients with type 2 diabetes showed a trend toward
reduced mtDNA content per cell in their omental adipose
tissue (ratio=0.71; p=0.1003; Table 4). These patients were
not treated with glitazones, PPAR-γ agonists, such as
rosiglitazone, which enhance mitochondrial biogenesis
leading to increased mitochondrial count and mass [22,
25]. The development of type 2 diabetes is believed to be
associated with impairment of mitochondria. This impair-
ment could be either due to a reduced mitochondrial
function or, as in our study, to a reduced mtDNA content
[32, 43]. Whether this is caused by misbalanced fusion and
fission processes as proposed for the development of
obesity and/or other defects is not yet understood [19].
Hence, a possible association could be found between
mtDNA content in omental adipose tissue and type 2
diabetes but remains subject to further analysis. In case
diabetic patients exhibit a clearly reduced amount of
mtDNA, this may be a plausible cause or a consequence
of impaired mitochondrial function. This observation of a
Table 5 Correlation of metabolic data and mitochondrial DNA content per adipocyte
Samples Spearman ratio 95% confidence interval pvalue
Basal metabolic rate 23 −0.3538 −0.6756 to 0.08142 0.0977
Basal metabolic rate per kilogram fat mass 23 0.1038 −0.3339 to 0.5046 0.6376
Fasting fat oxidation rate 22 −0.3123 −0.6562 to 0.1391 0.1571
Fasting fat oxidation rate per kilogram fat mass 22 −0.2897 −0.6418 to 0.1634 0.1910
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reduced mtDNA count in the diabetes group failed to be
significant. However, there is a 29% decrease in the mean
of the non-diabetes group compared to that of the diabetes
group, a relatively large but not significant effect. It can be
explained by the facts that we had a small diabetes group,
that we had patients at different stages of disease, and that
diabetes is concerning statistics a between subject effect
and is, therefore, poorly estimated. Originally, it was
planned to investigate the mtDNA content in obese vs.
non-obese control volunteers. At that time, the study was
not focused on diabetes. To study the impact of diabetes on
the mtDNA content in human adipose tissue, a further
analysis of diabetes patients is under way. We estimate that
another 30 diabetic patients have to be tested to elucidate
this observation of reduced mtDNA count in diabetes.
Interestingly, a significantly higher mtDNA copy num-
ber (ratio=1.56; p=0.0331; Table 4) was detected in the
group of obese patients compared to that of the non-obese
control group. A BMI of 30 was selected as it marks a
critical point in the transition from overweight to obesity.
Our observation is in contrast to a recent finding by
Kaaman et al. [35], who reported a decrease in mtDNA
content in subcutaneous adipose tissue in obesity. A
possible explanation for this discrepancy may be the
different types of adipose tissue analyzed in the two
studies. While Kaaman et al. used subcutaneous adipose
tissue pads for their analysis, we investigated omental
adipose tissue pads. This discrepancy may be an indication
for a different oxidative capacity in the two compartments
of adipose tissue, as has been shown for other metabolic
pathways, such as lipolytic capacity and the capacity to
secrete proteins [44–47].
A further explanation for an altered mtDNA content in
human omental adipose tissue of morbidly obese patients
may be found in a reduced expression of mitofusins
reported in obesity [20]. This leads to a more fragmented
mitochondrial population [21], which could attribute to the
mitochondrial content per cell.
Interestingly, diabetic patients show a decreased
mtDNA count, whereas obese patients have an increased
mtDNA copy number. This observation could account for
different mechanisms involved in the two diseases. While
mitochondrial mass—expressed by mtDNA count—of
omental adipose tissue might be upregulated in obesity
as a consequence of impaired function, this mechanism
does not seem to take place in diabetes. The view of
reduced activity of mitochondria in diabetes is supported
by a series of reports, such as the link of the metabolic
inflexibility from obese and type 2 diabetes patients with
decreased lipid peroxidation [48]. Clearly, further studies
investigating global mitochondrial function in type 2
diabetes have to be performed. In addition, the effect of
PPAR-γ agonists leading to induction of mitochondrial
biogenesis and resetting the mitochondrial mass demon-
strates the important link between mitochondria and
diabetes. The activation of mitochondrial biogenesis by
PPAR-γ agonists may lead to compensation of the
disturbed mitochondrial function and, thus, improve
diabetes treatment.
Lymphocytes from obese patients show a reduced citrate
synthase activity [49]. The same is demonstrated for muscle
biopsies, showing that mitochondrial parameters, including
citrate synthase activity, are reduced in obese patients [50].
In addition, a rat obesity model showed significantly
elevated hepatic mitochondrial mass and area, markedly
reduced citrate synthase activity but a stable number of
organelles in liver from rats fed a high-fat diet [51]. There
is no doubt that mitochondrial function is weakened in
obesity. This, together with changes in the morphology,
such as disturbed fusion and fission processes and altered
expression of proteins controlling morphology (e.g., mito-
fusins) [20], as well as changes in the mtDNA count,
clearly underline the tight association between mitochon-
dria and obesity. It remains difficult for some of these
observations to clarify what happens first: Are changes in
mitochondrial count and function a cause or consequence of
obesity?
Determination of the mtDNA content is based on sample
biopsies and, therefore, on an invasive technique. We
believe that the energy expenditure might be an alternative
non-invasive way to determine mitochondrial function and
mass. Energy expenditure can easily be measured with
calorimetry and analysis of the body composition. In a pilot
study we performed these measurements on 22 (fasting fat
oxidation) or 23 (basal metabolic rate) obese patients and
correlated the data with the mtDNA copy number. We
failed to detect any significant association between the
mtDNA content and the total basal metabolic rate, the basal
metabolic rate per kg fat mass, the total fat oxidation rate,
or the fat oxidation rate per kilogram fat mass (Table 5).
Keeping in mind that mitochondria of different tissues may
behave differently in number and function and that we
measured the basal metabolic rate and fat oxidation rate of
the whole organism, it is not surprising that we missed the
differences in the compartment of the omental fat tissue.
Furthermore, the range of BMI of the patients measured
was small, as was the range in their mtDNA count. Due to
logistics and other reasons we could not test non-obese
patients, who are now missing for a comparative analysis
with respect to BMI. Therefore, broadening the data
acquisition to include non-obese patients might give further
insights.
In summary, this investigation shows that omental
adipose tissue has a relatively stable number of mtDNA
copies per cell. Age, season, and gender have no impact.
The body mass index shows a significant association with
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the mtDNA copy number, whereas basal metabolic rate and
fat oxidation rate are not linked to mtDNA, supporting the
notion that mitochondria in omental adipose tissue only
exert a limited influence on whole-body energy homeosta-
sis (basal metabolic rate and expenditure). We identified a
trend toward reduced mtDNA content in diabetic patients.
The number of diabetics was, however, quite low, so further
studies may clarify this issue. MtDNA copy number clearly
increases with BMI. Whether there is first obesity and then
an increased mtDNA count, or vice versa, remains unclear
and needs further investigation.
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